An Immunocytochemical Approach to the Study of β‐Endorphin Production in Human Keratinocytes using Confocal Microscopy

ABSTRACT: Proopiomelanocortin (POMC) is a protein that is posttranslationally processed to yield POMC peptides. The main site of POMC expression is the anterior pituitary lobe but many other sources have been identified. There is evidence that the skin produces POMC peptides, although their roles have not yet been defined. In the skin, regulation of POMC gene expression is known to be hair‐cycle dependent, and it is localized to the sebaceous gland. In particular, β‐endorphin, a POMC peptide, has been shown to be modulated by TPA, IL‐1α, and ultraviolet radiation in keratinocytes. These results were obtained by examination of POMC mRNA levels using the Northern blot method; β‐endorphin protein production by the Western blot method on cultured cells; and immunocytochemistry for tissue preparations. This report represents an approach to use immunocytochemistry to quantify β‐endorphin production in cultured human keratinocytes. Additionally, we examined whether exposure to 20 mJ ultraviolet B radiation (UVB) and/or UVA could influence β‐endorphin production in these cells. Keratinocytes were grown in monolayers, in serum‐free medium, fixed, and incubated with antiserum to whole synthetic β‐endorphin. Fluorescence microscopy was performed with a confocal laser scanning microscope. The integrated level of fluorescence was evaluated in n= 18 ± 8 individual cells, and this was assumed to be proportional to β‐endorphin content. High variability was observed in the fluorescence intensity among cells. No significant differences between control and UVB‐ or UVA+UVB‐treated cells was found. Similar results were produced by using brefeldin A, a compound that disrupts the secretory pathway, eliminating the possibility that the absence of a difference between β‐endorphin content in the treated and control cells was due to secretion of the peptide into the medium. We conclude that: (1) β‐endorphin or β‐endorphin‐like peptides are produced in human keratinocytes and are readily detected by immunocytochemistry; (2) under the conditions tested, UVA and/or UVB did not increase β‐endorphin‐like immunoreactivity in these cells.

[1]  Y. Oiso,et al.  Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. , 1998, Endocrinology.

[2]  Y. Oiso,et al.  Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. I: Effects of the common secretagogues. , 1997, Endocrinology.

[3]  Y. Oiso,et al.  Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide. , 1997, Endocrinology.

[4]  S. Karki,et al.  Centractin (ARP1) associates with spectrin revealing a potential mechanism to link dynactin to intracellular organelles , 1996, The Journal of cell biology.

[5]  D. Ray,et al.  Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway. , 1996, The Journal of clinical investigation.

[6]  B. Gilchrest,et al.  Proopiomelanocortin gene product regulation in keratinocytes. , 1996, The Journal of investigative dermatology.

[7]  B. Gilchrest,et al.  Proopiomelanocortin, its derived peptides, and the skin. , 1996, The Journal of investigative dermatology.

[8]  M. Mortrud,et al.  DNA elements with AT-rich core sequences direct pituitary cell-specific expression of the pro-opiomelanocortin gene in transgenic mice. , 1995, The Biochemical journal.

[9]  V. Maino,et al.  Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. , 1995, Blood.

[10]  J. Roberts,et al.  Corticotropin-releasing hormone stimulates proopiomelanocortin transcription by cFos-dependent and -independent pathways: characterization of an AP1 site in exon 1. , 1995, Molecular endocrinology.

[11]  F. Gage,et al.  Retrovirus‐Mediated Expression of an Artificial β‐Endorphin Precursor in Primary Fibroblasts , 1995, Journal of neurochemistry.

[12]  M. Holick,et al.  The antiproliferative and differentiative activities of 1,25-dihydroxyvitamin D3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes. , 1995, The Journal of investigative dermatology.

[13]  J. Roberts,et al.  Characterization of a corticotropin-releasing hormone-responsive element in the rat proopiomelanocortin gene promoter and molecular cloning of its binding protein. , 1994, Molecular endocrinology.

[14]  F. Trautinger,et al.  Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes. , 1994, The Journal of clinical investigation.

[15]  J. Mazurkiewicz,et al.  Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. , 1993, The Journal of laboratory and clinical medicine.

[16]  G. Pelletier Regulation of Proopiomelanocortin Gene Expression in Rat Brain and Pituitary as Studied by In Situ Hybridization , 1993, Annals of the New York Academy of Sciences.

[17]  R. Paus,et al.  On the potential role of proopiomelanocortin in skin physiology and pathology , 1993, Molecular and Cellular Endocrinology.

[18]  R. Przewłocki,et al.  Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception , 1992, Neuroscience.

[19]  L. Terenius Chapter 31 Opioid peptides, pain and stress , 1992 .

[20]  L. Terenius Opioid peptides, pain and stress. , 1992, Progress in brain research.

[21]  H. Imura,et al.  Molecular mechanisms of glucocorticoid inhibition of human proopiomelanocortin gene transcription , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  P. Bornstein,et al.  Feedback regulation of collagen gene expression: a Trojan horse approach. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Roberts,et al.  Hormonal regulation of POMC gene expression. , 1989, Annual review of physiology.

[24]  Y. Ikehara,et al.  Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. , 1988, The Journal of biological chemistry.

[25]  W. Sossin,et al.  Multiple neuropeptides derived from a common precursor are differentially packaged and transported , 1988, Cell.

[26]  J. Roberts,et al.  Regulation of proopiomelanocortin gene expression in pituitary. , 1988, Endocrine reviews.

[27]  J. Funder,et al.  Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. , 1988, Endocrine reviews.

[28]  J. Lunec,et al.  Pigment-cells are able to synthesize MSH peptides , 1988 .

[29]  J. Eberwine,et al.  Glucocorticoid regulation of pro-opiomelanocortin gene transcription in the rat pituitary. , 1984, The Journal of biological chemistry.

[30]  J. Parrish,et al.  PLASMA β-ENDORPHIN AND β-LIPOTROPIN RESPONSE TO ULTRAVIOLET RADIATION , 1983, The Lancet.

[31]  N. Birnberg,et al.  Detection and quantitation of pro-opiomelanocortin mRNA in pituitary and brain tissues from different species. , 1982, The Journal of biological chemistry.

[32]  Stanley N Cohen,et al.  Characterization of the structural gene and putative 5′-regulatory sequences for human proopiomelanocortin , 1982, Nature.

[33]  S. Nakanishi,et al.  Isolation and structural organization of the human corticotropin‐β‐lipotropin precursor gene , 1981, FEBS letters.

[34]  D. Krieger,et al.  Presence of corticotropin in brain of normal and hypophysectomized rats. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[35]  H. Green,et al.  Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes , 1977, Nature.

[36]  Saunders Kb [The brown adipose tissue]. , 1965, Il Policlinico. Sezione pratica.